Bioelectronics Corp (BIEL)

[RVC]

Reality-is-that-we-need-different-company-leadership-to-bring-product-to-FDA-USA-Retail SEC efforts would tend to support this opinion as noted in http://www.sec.gov/litigation/admin/2016/33-10036.pdf

Interpretation from SEC proceedings are that current company leadership have diminished to near zero any investor confidence and botched past/current FDA efforts to the degree many investors have and will continue to be negatively impacted and the integrity of the company is now essentially questionable or in doubt at best.